AveXis Will Present Top-Line Data From Phase 1 Trial Of AVXS-101 In SMA Type 1 At WMS Conference; 'All patients were alive and event-free at 20 months of age as of the August 7, 2017 data cut-off'

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!